
Proteases play a pivotal role in biological processes, from digestion, cell proliferation and differentiation to fertility. Deregulation of protease metabolism can result in several pathological conditions (i.e., cancer, neurodegenerative disorders, etc). Monitoring proteolytic activity in real-time can ultimately help us understand the role of such enzymes within a certain condition. This may contribute to an early diagnosis, the follow-up of disease progression or the development of protease-targetted treatments (e.g. the current HIV treatment). In a recent paper published in Trends in Biochemical Sciences, Rui Oliveira-Silva and colleagues from BERG, CQE and University of Aveiro review the main approaches used to develop biosensors for monitoring proteolytic activity. A comparison of the advantages and disadvantages of each approach is provided along with a discussion of their importance and promising opportunities for the integration of such sensors into Personalized Medicine.